GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 793 filers reported holding GLAXOSMITHKLINE PLC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $863,000 | -0.8% | 21,481 | -0.5% | 0.99% | -2.1% |
Q2 2018 | $870,000 | -1.4% | 21,586 | -4.4% | 1.01% | +7.2% |
Q1 2018 | $882,000 | +7.7% | 22,576 | -2.3% | 0.94% | +19.6% |
Q4 2017 | $819,000 | -17.9% | 23,104 | -6.0% | 0.79% | -12.1% |
Q3 2017 | $998,000 | -6.1% | 24,569 | -0.4% | 0.90% | -11.1% |
Q2 2017 | $1,063,000 | +1.3% | 24,659 | -0.9% | 1.01% | +17.0% |
Q1 2017 | $1,049,000 | -57.6% | 24,879 | -56.6% | 0.86% | -61.4% |
Q3 2016 | $2,474,000 | -0.5% | 57,356 | 0.0% | 2.24% | +10.8% |
Q2 2016 | $2,486,000 | -8.4% | 57,356 | -14.3% | 2.02% | -10.3% |
Q1 2016 | $2,715,000 | +0.5% | 66,956 | 0.0% | 2.25% | +8.6% |
Q4 2015 | $2,702,000 | +105.6% | 66,956 | +95.9% | 2.08% | +85.9% |
Q3 2015 | $1,314,000 | -7.7% | 34,181 | 0.0% | 1.12% | +6.8% |
Q2 2015 | $1,424,000 | -9.7% | 34,181 | 0.0% | 1.04% | -10.1% |
Q1 2015 | $1,577,000 | +7.9% | 34,181 | 0.0% | 1.16% | +26.9% |
Q4 2014 | $1,461,000 | – | 34,181 | – | 0.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |